Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02859857
Title Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Kentucky Markey Cancer Center Lexington Kentucky 40536 United States Details
University of New Mexico Cancer Center Albuquerque New Mexico 87102 United States Details
University of Cincinnati Barrett Center Cincinnati Ohio 45219 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field